Evaluating and monitoring treatment response in depression using measurement-based assessment and rating scales.
Even with many treatment options available for major depressive disorder, many patients fail to achieve remission and return to their presymptomatic levels of functioning at work, in leisure activities, and in relationships. Throughout treatment, clinicians should implement measurement-based care by systematically monitoring patients' response using self-rated scales, such as the PHQ-9, QIDS-SR, or BDI. By tracking depressive symptoms, as well as suicidality, treatment adherence, and side effects, clinicians can adjust treatment to help patients achieve the best outcomes. Measurement-based care enables clinicians to make informed decisions at critical points throughout the treatment process and to involve patients in making those decisions.
Department of Psychiatry and Mood Disorders Research Program and Clinic, University of Texas Southwestern Medical Center, Dallas, USA.
Madhukar H
MH
Trivedi
D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D003863:Depression / Q000175:diagnosis / Q000188:drug therapy*; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology; D016903:Drug Monitoring / Q000379:methods*; D006801:Humans; D055118:Medication Adherence / Q000523:psychology; D017063:Outcome Assessment, Health Care / Q000379:methods; D010358:Patient Participation / Q000523:psychology; D011364:Professional Practice; D011569:Psychiatric Status Rating Scales; D011581:Psychological Tests; D059020:Suicidal Ideation; D016896:Treatment Outcome
D000928:Antidepressive Agents